US 11235056
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
granted A61KA61K2039/5258A61K2039/55555
Quick answer
US patent 11235056 (Glycan-masked engineered outer domains of HIV-1 gp120 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/5258, A61K2039/55555, A61K39/21, A61K39/295